First increase in five years for global funding for neglected diseases research, but Trump and Brexit cast doubts on future investment According to new data in the annual G-Finder report published today, the UK has regained its place as the second-largest funder of global health research focused on HIV & AIDS, tuberculosis, malaria, and neglected tropical diseases, as annual global …

Brussels, November 28, 2017: Ahead of World AIDS Day on December 1, a new report launched at the European Parliament today reveals that young people aged 10-24 remain underserved and overexposed to the risks of contracting HIV & AIDS, and other poverty-related diseases. The report calls on the EU to do more to help these young people – through education, …

Regulatory harmonization – a complex issue in the field of global health research and innovation. As part of our advocacy on increased investment by the EU in R&D, we have teamed up with our partners at PATH to see what the EU can do to support its African partners in improving the regulatory environment for health and drug development – …

DSW MEP Survey: MEPs support EU funding for disease research, reject Commission, Council threat of cuts Brussels, September 7, 2017: In the results of a new survey released today, a two-thirds majority of the European Parliament believes that the EU is not spending enough money to fund research that is targeted at HIV & AIDS, Tuberculosis, Malaria, and other diseases …

Our Imagine2030 wishes? Here at DSW, we have one big one for how the world will look or change by 2030: an end to diseases of poverty. No more HIV. No more Malaria. No more Tuberculosis. No more Neglected Tropical Diseases. We realise that this is not just going to happen all by itself, which is why we launched our Imagine2030 campaign in …

As part of the Imagine2030 campaign we want to show that innovation is not just something for the future. Biomedical advances being made right now will shape how we fight diseases of poverty in the future, and are delivering changes every day. We’re also not just focused on new medicines or tools, but also on innovative ideas about how to …

GFinder 2017 – EU overtakes UK in global health R&D funding rankings But declining international funding means worrying outlook for HIV & AIDS, TB, and malaria research According to new GFinder data released today, the European Union has become the second-largest funder of global health research focused on HIV & AIDS, tuberculosis, malaria, and neglected tropical diseases. EU support is …

Time is drawing near! Tomorrow, on December 1 (World AIDS Day), Deutsche Stiftung Weltbevölkerung (DSW) will be launching its campaign “Imagine2030: Invest in Innovation. End diseases of poverty”. The campaign will focus on raising awareness on the need to increase European political and financial support for global health innovation. This is essential if we are to eliminate diseases of poverty …

We believe in the power of innovation. Global health innovation to end diseases of poverty – causing the deaths of millions every year – is one of the key issues that we at DSW work on. We have some exciting news to announce later in the year on this, but for now we are delighted to host a guest editorial …

What do you really know about tuberculosis? If you are living in a high-income country, I imagine that you’ve probably heard of it but never really given it much thought. If this is the case, you should count yourself lucky, as the disease was one of the top ten causes of death and suffering in 2015. In fact, it has …